Navigation Links
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
Date:11/15/2009

ents. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    Helen G. Yang
    Sinovac Biotech Ltd.
    Tel:  +86-10-8289-0088 x9871
    Fax:  +86-10-6296-6910
    Email:  info@sinovac.com

    Investors:
    Amy Glynn/Stephanie Carrington
    The Ruth Group
    Tel:  +1-646-536-7023/7017
    Email:  aglynn@theruthgroup.com
    scarrington@theruthgroup.com

    Media
    Janine McCargo
    The Ruth Group
    Tel:  656-536-7033
    Email:  jmccargo@theruthgroup.com
    SINOVAC BIOTECH LTD.

    Consolidated Balance Sheets
    (Unaudited)
    (Expressed in U.S. Dollars)

                                          September 30,           December 31,
                                              2009                    2008

    ASSETS

    Current assets
     Cash and cash equivalents            $46,579,789           $32,894,102
     Accounts receivable - net             36,917,624            19,486,596
     Inventories                           13,541,462             6,486,351
     Income tax refundable                          -             
'/>"/>
SOURCE Sinovac Biotech Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
3. Sinovac to Present at 2009 UBS Global Life Sciences Conference
4. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. Sinovac Obtains Production License for H1N1 Vaccine
7. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
8. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
9. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
11. Sinovac Adjourns 2008 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... ... July 23, 2015 , ... One hundred years ago this year, ... Model Aeroplane Competition, with hopes of winning the Henry S. Villard Trophy. The Academy ... Participants will have the opportunity to build a Free Flight fantasy club worthy of ...
(Date:7/23/2015)... ... 23, 2015 , ... July 23, 2015, Chicago - Advances ... options with fewer side effects, according to Erik P. Sulman, MD, PhD, associate ... the American Brain Tumor Association (ABTA) National Patient and Family Conference in Chicago, ...
(Date:7/23/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian ... Limited (Biohaven), are pleased to announce that Biohaven ... with the U.S. Food and Drug Administration (FDA) ... 54% equity interest in Biohaven, a private company. ... and Biohaven has entered into an exclusive worldwide ...
(Date:7/23/2015)... -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS ), ... and the general public to its Annual Shareholder Meeting ... 31, 2015. The meeting will be held at the ... San Diego, California 92121.   ... available. Please use the following link to register for ...
Breaking Biology Technology:Academy of Model Aeronautics to Start Online Fantasy Flight Competition 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4OncoSec to Webcast Annual Meeting of Stockholders 2
... fast and easy detection of mycoplasma,contamination , ... Staggs ,Genetic Applications LLC , Heinz Miller ,Stratagene , ... potency of transfection reagents. 1 Cells must be ... ,transfection reagent and ...
... using LipoTAXI transfection reagent , Peter ... Karmiol ,Clonetics Corporation, Walkersville, Maryland , LipoTAXI ... that offers,low cellular toxicity and high transfection ... is described for optimizing the amounts of ...
... transfection reagent: A proven choice , ... transfection reagent offers,improved, ... growing in,suspension. In this article, we summarize the ... LipoTAXI reagent. Optimizing transfection,conditions is a critical, preliminary ...
Cached Biology Technology:Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 2Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 3Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells 2Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells 3Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells 4Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells 5Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 2Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 3Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 4Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 5Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 6Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 7
(Date:7/21/2015)... Sweden , July 21, 2015 Today, ... FPC1025. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... -- Summary Pancreatic cancer is the 12th most ... a mortality rate of 10.9 deaths per 100,000 people ... has highlighted a significant need for new and improved ... the current market. A highly active pancreatic cancer ... types and mechanisms of action, which provides a striking ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... natural selection favours traits that enhance dispersal of ... this theory, however, is relatively scarce. A study ... Biological and Environmental Sciences of the University of ... evolution of traits facilitating dispersal in an outer ...
... much iron is toxic, and can cause fatal organ failure. ... also be maintained. In a study published today in ... (EMBL) in Heidelberg, Germany, have discovered that a group of ... and as such are essential for cell survival. More specifically, ...
... ANN ARBOR, Mich.---In one of the first human studies ... the controversial chemical Bisphenol A, or BPA, may be related ... the researchers are quick to point out that these results ... documented adverse effects of BPA on semen in rodents, but ...
Cached Biology News:UH: Insular evolution: Large and big-footed voles in an outer archipelago 2Supply and demand 2Sperm may be harmed by exposure to BPA, study suggests 2
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
IC50: 35 ng/ml · Limit of detection: 8 ng/ml...
, Glycerol 30%...
Biology Products: